New York Hemp Laws: Delta-8, THCA and CBD Rules for 2026
Short answer: New York regulates cannabinoid hemp under 9 NYCRR Part 114, administered by the Office of Cannabis Management. Delta-8 and delta-10 are banned because Part 114 excludes synthetic, artificially derived and isomerized cannabinoids. Oral products are capped at 10 mg total THC per package and 1 mg per serving, and tinctures at 100 mg per package. Hemp flower is allowed within limits.
Last reviewed: November 5, 2026. New York’s cannabinoid hemp rules sit alongside the separate adult-use cannabis system, and the two are easy to confuse. This is educational information, not legal advice. Confirm the current requirements with the Office of Cannabis Management or a licensed New York attorney.
This page is part of our hemp laws by state guide, which compares eight states using primary-source citations.
New York hemp law at a glance
| Question | Position in New York |
|---|---|
| Governing rule | 9 NYCRR Part 114 (cannabinoid hemp) |
| Regulator | New York Office of Cannabis Management (OCM) |
| Total THC | Delta-9 THC plus THCA converted at 0.877 |
| Delta-8 and delta-10 | Prohibited as synthetic, artificially derived or isomerized cannabinoids |
| Oral products | 10 mg total THC per package; 1 mg per serving |
| Tinctures | 100 mg total THC per package |
| Hemp flower | Allowed with limits, including testing and labeling |
| Minimum age | 21 |
Two systems, one state
New York has a licensed adult-use cannabis market under the Marihuana Regulation and Taxation Act, and a separate cannabinoid hemp program under Part 114. The hemp program covers products made from hemp that are sold outside the licensed cannabis dispensary system.
That split matters because a product’s legal route depends on what it is and where it is sold. A delta-8 product cannot be sold as cannabinoid hemp in New York. Licensed cannabis products are governed by a different set of OCM rules, and even there the cannabinoid limits are not unlimited.
For a consumer, the practical rule is: if a New York retailer is selling delta-8 off a hemp shelf, the product does not fit Part 114.
The delta-8 and delta-10 ban
Part 114 §114.8(a)(11) prohibits cannabinoid hemp products that contain “synthetic cannabinoids, artificially derived cannabinoids, or cannabinoids created through isomerization, including, but not limited to, delta-8 tetrahydrocannabinol and delta-10 tetrahydrocannabinol.”
The wording is broad. It does not merely ban delta-8 by name; it bans the process category that produces it. Delta-8 is typically made by isomerizing CBD, so it falls inside the prohibition even when the starting material is hemp.
What that means in practice:
- Delta-8, delta-10 and similar isomerized cannabinoids cannot be sold as cannabinoid hemp in New York.
- HHC, THCO and other synthetically derived cannabinoids are not a workaround. They are outside the permitted category, and the federal definition also excludes several of them after November 12, 2026.
- Naturally occurring cannabinoids in a properly tested hemp product remain possible within the potency limits.
Potency limits: the numbers that decide the product
Part 114 sets limits by product type. The two most important are:
- Orally consumed products: no more than 10 mg total THC per package, with no more than 1 mg total THC per serving.
- Tinctures: no more than 100 mg total THC per package.
The rule also caps total cannabinoids per package at 3,000 mg for oral products and requires a CBD-to-THC ratio of 15:1 or higher for products other than flower and topicals, unless CBD is not the primary marketed cannabinoid. Those requirements make “high-potency” hemp edibles a poor fit for New York.
A 10 mg per-package cap is strict. A bag of 20 gummies at 5 mg each would contain 100 mg of total THC and fail, even if each individual gummy were within a per-serving limit. The package total is the binding number.
THCA and hemp flower
New York’s total THC definition includes THCA, so a high-THCA flower is measured on its converted value. Unlike California, New York allows hemp flower within limits, but the product still has to meet testing, labeling, packaging and potency requirements.
That creates a narrow lane. A low-THCA hemp flower can qualify. A typical “THCA flower” at 20% THCA cannot, because the converted total is far above the applicable limit. The name on the package does not change the math.
New York also requires cannabinoid hemp products sold in the state to be produced under a New York license, which affects out-of-state brands. The interstate-commerce limits of that requirement have been contested, but the rule remains the stated position.
CBD in New York
CBD is the mainstream cannabinoid hemp product in New York, and the rules are detailed:
- Testing — cannabinoid profile, potency, pesticides, heavy metals, microbials and residual solvents under §114.10.
- Labeling — cannabinoid content per serving and package, batch or lot, and required warnings.
- Packaging — child-resistant, tamper-evident and not appealing to minors.
- Potency — the 10 mg oral and 100 mg tincture caps above.
- Claims — no disease claims. CBD is not an approved drug.
CBD topicals and cosmetics are sold under separate rules. As in every state, the most common compliance failure is not the cannabinoid but the marketing copy and the absence of a batch-specific COA.
Shipping and buying across state lines
New York’s rule applies to products distributed or offered for retail sale in the state. Before ordering from an out-of-state seller:
- Is the product delta-8, delta-10 or another isomerized cannabinoid? If yes, it is not lawful cannabinoid hemp in New York.
- Does the COA report total THC with THCA converted? A delta-9-only report does not establish compliance.
- Does the package stay under the applicable milligram cap? Oral products are capped at 10 mg total THC per package; tinctures at 100 mg.
- Is the product made under a New York license? The state’s position is that cannabinoid hemp sold in New York must be produced under its program.
A brand that markets “delta-8” or “THCA flower” nationally is unlikely to be compliant in New York, regardless of what its checkout page allows.
The federal overlay after December 11, 2026
Federal law changes on November 12, 2026 and December 11, 2026. The first date removes cannabinoids the plant cannot naturally produce — including HHC and THCO — from the federal hemp definition. The second switches the federal measure to total THC including THCA at 0.3% dry weight and caps finished products at 0.4 mg total THC per container.
New York is already stricter than the federal floor on delta-8, delta-10 and potency. The federal container cap is not the main constraint for a 10 mg-per-package oral product, but it matters for tinctures and multi-serving products. A 100 mg tincture would exceed a 0.4 mg federal container cap after December 11, 2026, which is a direct conflict between state permission and federal limitation.
That conflict is unresolved. It is one more reason to check the current federal position before relying on a state allowance.
Frequently asked questions
Is delta-8 legal in New York?
No. Part 114 prohibits synthetic, artificially derived and isomerized cannabinoids, including delta-8 and delta-10, in cannabinoid hemp products. Delta-8 is typically made by isomerizing CBD, so it falls inside the ban.
How much THC is allowed in New York hemp products?
Orally consumed products are capped at 10 mg total THC per package and 1 mg per serving. Tinctures are capped at 100 mg total THC per package. Flower and topicals have separate requirements.
Is THCA flower legal in New York?
Hemp flower is allowed within limits, but total THC includes THCA. A high-THCA flower converts far above the applicable limit, so only low-THCA flower can qualify.
Can I buy CBD in New York?
Yes, if the product is tested, labeled, packaged and potency-compliant under Part 114 and sold to an adult 21 or older. CBD is not an approved drug and disease claims are not permitted.
Can an out-of-state brand sell hemp products in New York?
New York’s stated position is that cannabinoid hemp products sold in the state must be produced under a New York license. The interstate-commerce limits of that rule have been contested, so confirm the current enforcement position before shipping.
Related state guides
Sources
- 9 NYCRR Part 114, Cannabinoid Hemp
- 9 NYCRR §114.8 (cannabinoid hemp product requirements, including §114.8(a)(11))
- 9 NYCRR §114.10 (testing standards)
- New York Office of Cannabis Management, cannabinoid hemp program guidance
- Public Law 119-37, Division B, §781; Public Law 119-103, §2019
- Congressional Research Service, Changes to the Statutory Definition of Hemp (IF13136)
This page is educational and is not legal advice. New York’s rules and their interaction with federal law are subject to change; confirm the current position with the Office of Cannabis Management or a licensed New York attorney.